Spermidine

Evidence Fact Sheet

natural polyamine · wheat-germ extract

Spermidine is a natural dietary polyamine (wheat germ, soy, mushrooms, aged cheese) studied as an autophagy-inducing "healthy-aging" supplement. Human RCTs in older adults are mixed: a positive memory pilot but a null 12-month cognition trial; emerging immune and observational cardiovascular signals. Lawful supplement; no authorized health claim.

Also known as: N-(3-aminopropyl)-1,4-butanediamine · Wheat germ extract (spermidine-standardized)

Overview

Spermidine is a naturally occurring polyamine found in wheat germ, soybeans, mushrooms and aged cheese, sold as a supplement typically standardized in spermidine-rich wheat-germ extract. Its researched mechanism is induction of cellular autophagy (via EP300 acetyltransferase inhibition) and eIF5A hypusination supporting mitochondrial function — largely preclinical/mechanistic context. Human research dosing in the cognition RCTs falls roughly in the 1-6 mg/day spermidine range (delivered as several grams of extract); a separate safety RCT tested 40 mg/day. In the US it is a lawful dietary-supplement ingredient under DSHEA (structure/function claims only); it is sold as a food supplement in the EU, and the wheat-germ-derived form is treated as a common-food ingredient in China. There is no FDA-authorized or EFSA-authorized health claim for spermidine, and ANVISA status is to be confirmed.

Mechanism of Action

Autophagy induction via EP300 acetyltransferase inhibition (research context · preclinical/mechanistic) · eIF5A hypusination supporting mitochondrial function (mechanistic) · Epigenetic modulation of histone acetylation state · Immune-cell (T-cell) differentiation modulation (ex vivo research)

Body systems: Neurological & Cognitive · Cellular Renewal · Mitochondrial & Cellular Energy · Immune System

Evidence-Based Benefits

Each benefit below is anchored to a specific PubMed-indexed study. Effect sizes, sample sizes, and p-values are reported as published; no values are inferred. Honest negatives and null results are kept alongside the positive findings, and disease-research populations are described as such — Spermidine is not characterized as a treatment for any disease.

Cognition / Memory (12-Month RCT, Null)

Null / no benefit RCT supported

n=100older adults · SCD
−0.03between-group · 95% CI −0.11 to 0.05
P = .47mnemonic discrimination · 12 mo

In the SmartAge randomized clinical trial, 12 months of spermidine supplementation in older adults with subjective cognitive decline did not improve the primary memory endpoint (mnemonic discrimination) versus placebo. This is an honest negative: the largest and longest spermidine cognition RCT to date was null on its primary outcome, with only exploratory signals (verbal memory, inflammation) flagged for future validation.

Reported effect: Between-group difference −0.03 (95% CI, −0.11 to 0.05; P = .47) for mnemonic discrimination over 12 months; n=100 randomized.

“Over 12 months, no significant changes were observed in mnemonic discrimination performance (between-group difference, -0.03; 95% CI, -0.11 to 0.05; P = .47)”

Source: PMID 35616942 · Schwarz 2022 · JAMA Netw Open

Cognition / Memory (3-Month Pilot RCT, Positive)

RCT supported

Cohen's d = .77memory · 95% CI 0 to 1.53
n=30at-risk older adults
3 monthsduration

In an earlier 3-month Phase IIa pilot RCT in older adults at risk for dementia, spermidine-rich extract moderately enhanced memory performance versus placebo, with a medium-to-large effect size. As a small pilot it is hypothesis-generating; its positive signal was not confirmed by the later, larger 12-month SmartAge trial.

Reported effect: Memory performance moderately enhanced vs placebo: contrast mean .17 (95% CI −.01 to .35), Cohen's d = .77 (95% CI 0 to 1.53); n=30 over 3 months.

“Memory performance was moderately enhanced in the spermidine group compared with placebo at the end of intervention [contrast mean = .17, 95% confidence interval (CI): -.01, .35, Cohen's d = .77, 95% CI: 0, 1.53].”

Source: PMID 30388439 · Wirth 2018 · Cortex

Cardiovascular / Blood Pressure (Human Cohort)

Emerging / indexed

829human participants

Within a largely preclinical cardioprotection study, a human observational cohort found that higher dietary spermidine intake correlated with reduced blood pressure and a lower incidence of cardiovascular disease. These are correlational associations from food-questionnaire data, not from a randomized trial, so causality is not established.

Reported effect: Observational association in 829 participants: higher dietary spermidine correlated with reduced blood pressure and lower cardiovascular disease incidence (no randomized effect size).

“In humans, high levels of dietary spermidine, as assessed from food questionnaires, correlated with reduced blood pressure and a lower incidence of cardiovascular disease.”

Source: PMID 27841876 · Eisenberg 2016 · Nat Med

Immune Senescence / Vaccine Response (Pilot RCT)

RCT supported

In a double-blind, randomized, placebo-controlled pilot study in 40 adults over 65 following a third SARS-CoV-2 vaccine dose, spermidine (6 mg/day for 13 weeks) was well-tolerated and significantly enhanced spike-specific IgG, memory B-cell recall and neutralizing antibody activity, specifically in vaccine non-responders. The abstract reports the direction as significant but does not give an extractable numeric effect size, and it is a small pilot.

Effect size: this study reports the direction of the finding but does not state a specific numeric effect size, so none is given here rather than estimated.

“Spermidine reversed these features and significantly enhanced spike-specific IgG secretion, memory B cell recall responses and neutralising antibody activity, specifically in non-responders.”

Source: PMID 42169618 · Alsaleh 2026 · Aging Cell

Polyamine Pharmacokinetics / Safety (High-Dose RCT, Null)

Null / no benefit RCT supported

40 mg/dayhighly purified spermidine
n=37healthy men

An exploratory double-blind RCT gave healthy older men 40 mg/day of highly purified spermidine and found no substantial change in serum or urine polyamine concentrations and no significant clinical, lipid, chemistry or hematological changes versus placebo. This is an honest negative on pharmacokinetics: even a high dose did not measurably raise circulating polyamines, suggesting tight homeostatic control — though it confirms good short-term tolerability.

Reported effect: No substantial change in serum/urine polyamine concentrations at 40 mg/day; n=37 healthy men, well-tolerated with no adverse events.

“Substantial changes in serum and urine polyamine concentrations were not observed following hpSPD supplementation, suggesting effective homeostatic control of full-dose highly purified spermidine supplements with no evidence of adaptation of spermidine metabolism at 40 mg/day.”

Source: PMID 39405978 · Keohane 2024 · Nutr Res

Dosage (research context · not a recommendation)

1-6 mg/day spermidine in the two cognition RCTs (delivered as spermidine-rich wheat-germ extract, several grams of extract). Educational reference only; not a dosing recommendation. Long-term high-dose human safety data limited.

Regulatory Status · 4 Markets

US · FDA: Lawful dietary-supplement ingredient (spermidine / wheat-germ extract standardized to spermidine) under DSHEA; structure/function claims only (e.g. 'cellular renewal support', 'healthy aging support'). NO FDA authorized or qualified health claim for spermidine.
EU · EFSA: Spermidine-rich wheat-germ extract is sold as a food supplement in the EU (a primary spermidine research/market region · Austria TLL/Longevity Labs); NO EFSA-authorized health claim under Reg 432/2012. Synthetic spermidine may face a different (Novel Food) regulatory path than the natural wheat-germ source.
CN · China: Marketable as a food-derived substance: spermidine-rich wheat-germ extract is sourced from wheat germ, a conventional food in China, so it is treated as a common-food ingredient; no SAMR health-food registration. Isolated/synthetic spermidine would need separate novel-food review.
BR · ANVISA: Spermidine's explicit status as a food-supplement ingredient under RDC 243/2018 / IN 28/2018 is to be confirmed (status to be confirmed); NO Anexo V alegação funcional for spermidine.

Safety

Spermidine is a natural dietary polyamine (wheat germ, soy, mushrooms, aged cheese) with a good tolerability profile at food-relevant intakes; the two RCTs (1-6 mg/day for 3-12 months) reported no major safety concerns. High-dose and beyond-12-month human safety data are limited. Wheat-germ-derived extracts are not suitable for people with wheat/gluten sensitivity. Pregnancy/lactation data inadequate. Educational, not medical advice.

Goals: longevity-stack · cognitive-support

Lifestyles: senior-60-plus

References

PubMed-indexed citations anchoring the benefit findings above. Effect sizes are reported as published.

PMID 35616942 · Schwarz 2022 · JAMA Netw Open — Cognition / Memory (12-Month RCT, Null)
PMID 30388439 · Wirth 2018 · Cortex — Cognition / Memory (3-Month Pilot RCT, Positive)
PMID 27841876 · Eisenberg 2016 · Nat Med — Cardiovascular / Blood Pressure (Human Cohort)
PMID 42169618 · Alsaleh 2026 · Aging Cell — Immune Senescence / Vaccine Response (Pilot RCT)
PMID 39405978 · Keohane 2024 · Nutr Res — Polyamine Pharmacokinetics / Safety (High-Dose RCT, Null)

Frequently Asked Questions

1. Does spermidine actually improve memory in older adults?

The evidence is mixed and leans cautious. A small 3-month pilot RCT (n=30) found a moderate memory benefit (Cohen's d = .77), but the larger, longer 12-month SmartAge RCT (n=100) was null on its primary memory endpoint (between-group difference −0.03; P = .47). So the early positive signal was not confirmed in the better-powered trial, and memory benefit in older adults remains unproven.

2. What is spermidine and how is it thought to work?

Spermidine is a natural polyamine found in foods like wheat germ, soy, mushrooms and aged cheese, sold mainly as spermidine-rich wheat-germ extract. Its most-studied proposed mechanism is induction of cellular autophagy (the cell's recycling process), plus support of mitochondrial function via eIF5A hypusination — but most of this mechanistic work is preclinical, not based on human clinical endpoints.

3. What dose is used in research, and is it safe?

The two cognition RCTs used roughly 1-6 mg/day of spermidine delivered as several grams of wheat-germ extract; a separate safety RCT tested 40 mg/day in 37 healthy men and found it well-tolerated with no adverse events. These are research doses, not a dosing recommendation. Long-term and beyond-12-month human safety data are limited, and wheat-germ-derived extracts are not suitable for people with wheat or gluten sensitivity.

4. Is there a downside or negative finding worth knowing?

Yes — two honest negatives. The main 12-month cognition trial missed its primary endpoint, and the 40 mg/day pharmacokinetic RCT found no substantial change in serum or urine polyamine levels even at high dose, pointing to tight homeostatic control. The cardiovascular blood-pressure data (829 participants) are observational associations, not proof of cause and effect.

5. Can spermidine boost vaccine responses?

A double-blind pilot RCT in 40 adults over 65 (6 mg/day for 13 weeks) reported that spermidine significantly enhanced spike-specific IgG, memory B-cell recall and neutralizing antibody activity, specifically in vaccine non-responders. This is an early, small pilot finding reported as significant but without an extractable numeric effect size, so it needs larger confirmatory trials before any conclusions.

Last evidence review: 2026-06-13

← Evidence library